Last 12 months
Inside the activity.
13 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 13 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 29, 2024 Filed Apr 2, 2024 20:38 UTC |
Cobourn Steven P.Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 93,900 | $0.00 Strike: $2.23 | $0.00 |
DisclosureSEC source: 0000905148-24-001049 · form4.xml · derivative · entry 1 Cobourn Steven P. · CIK 0001775457 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,900 Underlying: Common Stock · 93,900 shares Expires 2034-03-28 F1 · derivative.exercise_date: The option vests in full on the one year anniversary of the grant, March 29, 2025. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 16:44 UTC |
Mayer TimothyChief Operating Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 117,375 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0000905148-24-000393 · form4.xml · derivative · entry 1 Mayer Timothy · CIK 0001775460 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,375 Underlying: Common Stock · 117,375 shares Expires 2034-01-30 F1 · derivative.exercise_date: One fourth of the option vests on January 31, 2025. The remainder vests in 36 monthly installments beginning on February 28, 2025. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 16:45 UTC |
Richman MichaelDirector · President & CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 305,500 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0000905148-24-000395 · form4.xml · derivative · entry 1 Richman Michael · CIK 0001366265 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 305,500 Underlying: Common Stock · 305,500 shares Expires 2034-01-30 F1 · derivative.exercise_date: One fourth of the option vests on January 31, 2025. The remainder vests in 36 monthly installments beginning on February 28, 2025. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 21:45 UTC |
Shaw Kevin G.Sr VP, General Counsel
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 66,125 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0000905148-24-000396 · form4.xml · derivative · entry 1 Shaw Kevin G. · CIK 0001953666 · Sr VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,125 Underlying: Common Stock · 66,125 shares Expires 2034-01-30 F1 · derivative.exercise_date: One fourth of the option vests on January 31, 2025. The remainder vests in 36 monthly installments beginning on February 28, 2025. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 21:44 UTC |
Langermann SolChief Scientific Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 117,375 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0000905148-24-000392 · form4.xml · derivative · entry 1 Langermann Sol · CIK 0001775459 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,375 Underlying: Common Stock · 117,375 shares Expires 2034-01-30 F1 · derivative.exercise_date: One fourth of the option vests on January 31, 2025. The remainder vests in 36 monthly installments beginning on February 28, 2025. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 21:45 UTC |
Myint HanChief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 117,375 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0000905148-24-000394 · form4.xml · derivative · entry 1 Myint Han · CIK 0001840942 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,375 Underlying: Common Stock · 117,375 shares Expires 2034-01-30 F1 · derivative.exercise_date: One fourth of the option vests on January 31, 2025. The remainder vests in 36 monthly installments beginning on February 28, 2025. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 21:43 UTC |
Kundu SouravSr VP, Dev. & Mfg.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 66,125 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0000905148-24-000391 · form4.xml · derivative · entry 1 Kundu Sourav · CIK 0001872985 · Sr VP, Dev. & Mfg. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,125 Underlying: Common Stock · 66,125 shares Expires 2034-01-30 F1 · derivative.exercise_date: One fourth of the option vests on January 31, 2025. The remainder vests in 36 monthly installments beginning on February 28, 2025. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 21:43 UTC |
Cobourn Steven P.Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 117,375 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0000905148-24-000390 · form4.xml · derivative · entry 1 Cobourn Steven P. · CIK 0001775457 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,375 Underlying: Common Stock · 117,375 shares Expires 2034-01-30 F1 · derivative.exercise_date: One fourth of the option vests on January 31, 2025. The remainder vests in 36 monthly installments beginning on February 28, 2025. Read SEC document |
| June 22, 2023 Filed Jun 23, 2023 20:31 UTC |
KABAKOFF DAVID SDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001140361-23-031194 · form4.xml · derivative · entry 1 KABAKOFF DAVID S · CIK 0001024008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2033-06-21 F1 · derivative.exercise_date: The option vests in full on the earlier of June 22, 2024 and the date of the 2024 Annual Meeting of Stockholders. Read SEC document |
| June 22, 2023 Filed Jun 23, 2023 20:30 UTC |
Borgman Anne ElizabethDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001140361-23-031187 · form4.xml · derivative · entry 1 Borgman Anne Elizabeth · CIK 0001886388 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2033-06-21 F1 · derivative.exercise_date: The option vests in full on the earlier of June 22, 2024 and the date of the 2024 Annual Meeting of Stockholders. Read SEC document |
| June 22, 2023 Filed Jun 23, 2023 20:30 UTC |
Webster Stephen WDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001140361-23-031188 · form4.xml · derivative · entry 1 Webster Stephen W · CIK 0001438421 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2033-06-21 F1 · derivative.exercise_date: The option vests in full on the earlier of June 22, 2024 and the date of the 2024 Annual Meeting of Stockholders. Read SEC document |
| June 22, 2023 Filed Jun 23, 2023 20:30 UTC |
Jones Elaine VDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001140361-23-031189 · form4.xml · derivative · entry 1 Jones Elaine V · CIK 0001296907 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2033-06-21 F1 · derivative.exercise_date: The option vests in full on the earlier of June 22, 2024 and the date of the 2024 Annual Meeting of Stockholders. Read SEC document |
| June 22, 2023 Filed Jun 23, 2023 16:31 UTC |
Khuong Chau QuangDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001140361-23-031192 · form4.xml · derivative · entry 1 Khuong Chau Quang · CIK 0001609405 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2033-06-21 F1 · derivative.exercise_date: The option vests in full on the earlier of June 22, 2024 and the date of the 2024 Annual Meeting of Stockholders. Read SEC document |
| June 22, 2023 Filed Jun 23, 2023 20:31 UTC |
Nicholson Garry ADirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001140361-23-031195 · form4.xml · derivative · entry 1 Nicholson Garry A · CIK 0001640861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2033-06-21 F1 · derivative.exercise_date: The option vests in full on the earlier of June 22, 2024 and the date of the 2024 Annual Meeting of Stockholders. Read SEC document |
| June 22, 2023 Filed Jun 23, 2023 20:30 UTC |
Houston John GDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001140361-23-031191 · form4.xml · derivative · entry 1 Houston John G · CIK 0001753537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2033-06-21 F1 · derivative.exercise_date: The option vests in full on the earlier of June 22, 2024 and the date of the 2024 Annual Meeting of Stockholders. Read SEC document |
| June 22, 2023 Filed Jun 23, 2023 20:30 UTC |
Feigal EllenDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001140361-23-031190 · form4.xml · derivative · entry 1 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2033-06-21 F1 · derivative.exercise_date: The option vests in full on the earlier of June 22, 2024 and the date of the 2024 Annual Meeting of Stockholders. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 18:02 UTC |
Mayer TimothyChief Operating Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 135,000 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001140361-23-009494 · form4.xml · derivative · entry 1 Mayer Timothy · CIK 0001775460 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 135,000 shares Expires 2033-02-27 F1 · derivative.exercise_date: One fourth of the option vests on February 28, 2024. The remainder vests in 36 monthly installments beginning on March 28, 2024. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 18:01 UTC |
Richman MichaelDirector · President & CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 309,000 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001140361-23-009489 · form4.xml · derivative · entry 1 Richman Michael · CIK 0001366265 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,000 Underlying: Common Stock · 309,000 shares Expires 2033-02-27 F1 · derivative.exercise_date: One fourth of the option vests on February 28, 2024. The remainder vests in 36 monthly installments beginning on March 28, 2024. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 23:02 UTC |
Kundu SouravSr VP, Dev. & Mfg.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001140361-23-009493 · form4.xml · derivative · entry 1 Kundu Sourav · CIK 0001872985 · Sr VP, Dev. & Mfg. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2033-02-27 F1 · derivative.exercise_date: One fourth of the option vests on February 28, 2024. The remainder vests in 36 monthly installments beginning on March 28, 2024. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 23:01 UTC |
Myint HanChief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 135,000 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001140361-23-009492 · form4.xml · derivative · entry 1 Myint Han · CIK 0001840942 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 135,000 shares Expires 2033-02-27 F1 · derivative.exercise_date: One fourth of the option vests on February 28, 2024. The remainder vests in 36 monthly installments beginning on March 28, 2024. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 23:01 UTC |
Shaw Kevin G.Sr VP, Legal Affairs
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001140361-23-009491 · form4.xml · derivative · entry 1 Shaw Kevin G. · CIK 0001953666 · Sr VP, Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2033-02-27 F1 · derivative.exercise_date: One fourth of the option vests on February 28, 2024. The remainder vests in 36 monthly installments beginning on March 28, 2024. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 23:01 UTC |
Langermann SolChief Scientific Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 135,000 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001140361-23-009490 · form4.xml · derivative · entry 1 Langermann Sol · CIK 0001775459 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 135,000 shares Expires 2033-02-27 F1 · derivative.exercise_date: One fourth of the option vests on February 28, 2024. The remainder vests in 36 monthly installments beginning on March 28, 2024. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 23:01 UTC |
Cobourn Steven P.Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 135,000 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001140361-23-009488 · form4.xml · derivative · entry 1 Cobourn Steven P. · CIK 0001775457 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 135,000 shares Expires 2033-02-27 F1 · derivative.exercise_date: One fourth of the option vests on February 28, 2024. The remainder vests in 36 monthly installments beginning on March 28, 2024. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 21:21 UTC |
KABAKOFF DAVID SDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $4.77 | $0.00 |
DisclosureSEC source: 0001567619-22-013366 · doc1.xml · derivative · entry 1 KABAKOFF DAVID S · CIK 0001024008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2032-06-22 F1 · derivative.exercise_date: The option vests in full on the earlier of June 23, 2023 and the date of the 2023 Annual Meeting of Stockholders. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 21:32 UTC |
Borgman Anne ElizabethDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $4.77 | $0.00 |
DisclosureSEC source: 0001567619-22-013372 · doc1.xml · derivative · entry 1 Borgman Anne Elizabeth · CIK 0001886388 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2032-06-22 F1 · derivative.exercise_date: The option vests in full on the earlier of June 23, 2023 and the date of the 2023 Annual Meeting of Stockholders. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 21:28 UTC |
Webster Stephen WDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $4.77 | $0.00 |
DisclosureSEC source: 0001567619-22-013369 · doc1.xml · derivative · entry 1 Webster Stephen W · CIK 0001438421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2032-06-22 F1 · derivative.exercise_date: The option vests in full on the earlier of June 23, 2023 and the date of the 2023 Annual Meeting of Stockholders. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 21:23 UTC |
Jones Elaine VDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $4.77 | $0.00 |
DisclosureSEC source: 0001567619-22-013367 · doc1.xml · derivative · entry 1 Jones Elaine V · CIK 0001296907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2032-06-22 F1 · derivative.exercise_date: The option vests in full on the earlier of June 23, 2023 and the date of the 2023 Annual Meeting of Stockholders. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 17:25 UTC |
Khuong Chau QuangDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $4.77 | $0.00 |
DisclosureSEC source: 0001567619-22-013368 · doc1.xml · derivative · entry 1 Khuong Chau Quang · CIK 0001609405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2032-06-22 F1 · derivative.exercise_date: The option vests in full on the earlier of June 23, 2023 and the date of the 2023 Annual Meeting of Stockholders. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 21:29 UTC |
Nicholson Garry ADirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $4.77 | $0.00 |
DisclosureSEC source: 0001567619-22-013370 · doc1.xml · derivative · entry 1 Nicholson Garry A · CIK 0001640861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2032-06-22 F1 · derivative.exercise_date: The option vests in full on the earlier of June 23, 2023 and the date of the 2023 Annual Meeting of Stockholders. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 21:33 UTC |
Feigal EllenDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $4.77 | $0.00 |
DisclosureSEC source: 0001567619-22-013373 · doc1.xml · derivative · entry 1 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2032-06-22 F1 · derivative.exercise_date: The option vests in full on the earlier of June 23, 2023 and the date of the 2023 Annual Meeting of Stockholders. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 21:30 UTC |
Houston John GDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $4.77 | $0.00 |
DisclosureSEC source: 0001567619-22-013371 · doc1.xml · derivative · entry 1 Houston John G · CIK 0001753537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2032-06-22 F1 · derivative.exercise_date: The option vests in full on the earlier of June 23, 2023 and the date of the 2023 Annual Meeting of Stockholders. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 16:17 UTC |
Mayer TimothyChief Operating Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 131,200 | $0.00 Strike: $5.57 | $0.00 |
DisclosureSEC source: 0000905148-22-000159 · form4.xml · derivative · entry 1 Mayer Timothy · CIK 0001775460 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,200 Underlying: Common Stock · 131,200 shares Expires 2032-01-30 F1 · derivative.exercise_date: One fourth of the option vests on January 31, 2023. The remainder vests in 36 monthly installments beginning on February 28, 2023. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 16:18 UTC |
Richman MichaelDirector · President & CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 262,400 | $0.00 Strike: $5.57 | $0.00 |
DisclosureSEC source: 0000905148-22-000160 · form4.xml · derivative · entry 1 Richman Michael · CIK 0001366265 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,400 Underlying: Common Stock · 262,400 shares Expires 2032-01-30 F1 · derivative.exercise_date: One fourth of the option vests on January 31, 2023. The remainder vests in 36 monthly installments beginning on February 28, 2023. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:22 UTC |
Liu LindaSVP, Research
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 65,600 | $0.00 Strike: $5.57 | $0.00 |
DisclosureSEC source: 0000905148-22-000163 · form4.xml · derivative · entry 1 Liu Linda · CIK 0001775427 · SVP, Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,600 Underlying: Common Stock · 65,600 shares Expires 2032-01-30 F1 · derivative.exercise_date: One fourth of the option vests on January 31, 2023. The remainder vests in 36 monthly installments beginning on February 28, 2023. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:20 UTC |
Langermann SolChief Scientific Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 117,400 | $0.00 Strike: $5.57 | $0.00 |
DisclosureSEC source: 0000905148-22-000162 · form4.xml · derivative · entry 1 Langermann Sol · CIK 0001775459 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,400 Underlying: Common Stock · 117,400 shares Expires 2032-01-30 F1 · derivative.exercise_date: One fourth of the option vests on January 31, 2023. The remainder vests in 36 monthly installments beginning on February 28, 2023. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:19 UTC |
Kundu SouravSr VP, Dev. & Mfg.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 58,700 | $0.00 Strike: $5.57 | $0.00 |
DisclosureSEC source: 0000905148-22-000161 · form4.xml · derivative · entry 1 Kundu Sourav · CIK 0001872985 · Sr VP, Dev. & Mfg. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,700 Underlying: Common Stock · 58,700 shares Expires 2032-01-30 F1 · derivative.exercise_date: One fourth of the option vests on January 31, 2023. The remainder vests in 36 monthly installments beginning on February 28, 2023. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:16 UTC |
Cobourn Steven P.Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 96,700 | $0.00 Strike: $5.57 | $0.00 |
DisclosureSEC source: 0000905148-22-000158 · form4.xml · derivative · entry 1 Cobourn Steven P. · CIK 0001775457 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,700 Underlying: Common Stock · 96,700 shares Expires 2032-01-30 F1 · derivative.exercise_date: One fourth of the option vests on January 31, 2023. The remainder vests in 36 monthly installments beginning on February 28, 2023. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:15 UTC |
Myint HanChief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 103,600 | $0.00 Strike: $5.57 | $0.00 |
DisclosureSEC source: 0000905148-22-000157 · form4.xml · derivative · entry 1 Myint Han · CIK 0001840942 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,600 Underlying: Common Stock · 103,600 shares Expires 2032-01-30 F1 · derivative.exercise_date: One fourth of the option vests on January 31, 2023. The remainder vests in 36 monthly installments beginning on February 28, 2023. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:05 UTC |
Borgman Anne ElizabethDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,384 | $0.00 Strike: $7.56 | $0.00 |
DisclosureSEC source: 0001567619-21-017920 · doc1.xml · derivative · entry 2 Borgman Anne Elizabeth · CIK 0001886388 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,384 Underlying: Common Stock · 10,384 shares Expires 2031-09-30 F2 · derivative.exercise_date: The option vests in full on the earlier of June 24, 2022 and the date of the 2022 Annual Meeting of Stockholders. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:05 UTC |
Borgman Anne ElizabethDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,500 | $0.00 Strike: $7.56 | $0.00 |
DisclosureSEC source: 0001567619-21-017920 · doc1.xml · derivative · entry 1 Borgman Anne Elizabeth · CIK 0001886388 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,500 Underlying: Common Stock · 28,500 shares Expires 2031-09-30 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on October 1, 2021. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:08 UTC |
Feigal EllenDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,384 | $0.00 Strike: $7.56 | $0.00 |
DisclosureSEC source: 0001567619-21-017925 · doc1.xml · derivative · entry 2 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,384 Underlying: Common Stock · 10,384 shares Expires 2031-09-30 F2 · derivative.exercise_date: The option vests in full on the earlier of June 24, 2022 and the date of the 2022 Annual Meeting of Stockholders. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:08 UTC |
Feigal EllenDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,500 | $0.00 Strike: $7.56 | $0.00 |
DisclosureSEC source: 0001567619-21-017925 · doc1.xml · derivative · entry 1 Feigal Ellen · CIK 0001758108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,500 Underlying: Common Stock · 28,500 shares Expires 2031-09-30 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on October 1, 2021. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 20:07 UTC |
Kundu SouravSr VP, Dev. & Mfg.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $7.89 | $0.00 |
DisclosureSEC source: 0001567619-21-013638 · doc1.xml · derivative · entry 1 Kundu Sourav · CIK 0001872985 · Sr VP, Dev. & Mfg. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2031-07-05 F1 · derivative.exercise_date: One fourth of the option vests on July 6, 2022. The remainder vests in 36 monthly installments beginning on August 6, 2022. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 22:15 UTC |
KABAKOFF DAVID SDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $8.21 | $0.00 |
DisclosureSEC source: 0001567619-21-012669 · doc1.xml · derivative · entry 1 KABAKOFF DAVID S · CIK 0001024008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2031-06-23 F1 · derivative.exercise_date: The option vests in full on the earlier of June 24, 2022 and the date of the 2022 Annual Meeting of Stockholders. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 22:10 UTC |
Webster Stephen WDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $8.21 | $0.00 |
DisclosureSEC source: 0001567619-21-012667 · doc1.xml · derivative · entry 1 Webster Stephen W · CIK 0001438421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2031-06-23 F1 · derivative.exercise_date: The option vests in full on the earlier of June 24, 2022 and the date of the 2022 Annual Meeting of Stockholders. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 22:13 UTC |
Jones Elaine VDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $8.21 | $0.00 |
DisclosureSEC source: 0001567619-21-012668 · doc1.xml · derivative · entry 1 Jones Elaine V · CIK 0001296907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2031-06-23 F1 · derivative.exercise_date: The option vests in full on the earlier of June 24, 2022 and the date of the 2022 Annual Meeting of Stockholders. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 18:09 UTC |
Khuong Chau QuangDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $8.21 | $0.00 |
DisclosureSEC source: 0001567619-21-012666 · doc1.xml · derivative · entry 1 Khuong Chau Quang · CIK 0001609405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2031-06-23 F1 · derivative.exercise_date: The option vests in full on the earlier of June 24, 2022 and the date of the 2022 Annual Meeting of Stockholders. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 22:18 UTC |
Nicholson Garry ADirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $8.21 | $0.00 |
DisclosureSEC source: 0001567619-21-012671 · doc1.xml · derivative · entry 1 Nicholson Garry A · CIK 0001640861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2031-06-23 F1 · derivative.exercise_date: The option vests in full on the earlier of June 24, 2022 and the date of the 2022 Annual Meeting of Stockholders. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 22:21 UTC |
Houston John GDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $8.21 | $0.00 |
DisclosureSEC source: 0001567619-21-012672 · doc1.xml · derivative · entry 1 Houston John G · CIK 0001753537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2031-06-23 F1 · derivative.exercise_date: The option vests in full on the earlier of June 24, 2022 and the date of the 2022 Annual Meeting of Stockholders. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 22:16 UTC |
Xu StellaDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,250 | $0.00 Strike: $8.21 | $0.00 |
DisclosureSEC source: 0001567619-21-012670 · doc1.xml · derivative · entry 1 Xu Stella · CIK 0001728741 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 14,250 shares Expires 2031-06-23 F1 · derivative.exercise_date: The option vests in full on the earlier of June 24, 2022 and the date of the 2022 Annual Meeting of Stockholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.